• bitcoinBitcoin(BTC)$63,282.00-0.20%
  • ethereumEthereum(ETH)$1,784.080.11%
  • tetherTether(USDT)$1.000.01%
  • binancecoinBNB(BNB)$587.760.33%
  • usd-coinUSDC(USDC)$1.000.00%
  • rippleXRP(XRP)$0.98-0.80%
  • solanaSolana(SOL)$74.190.22%
  • tronTRON(TRX)$0.3106070.66%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.031.94%
  • HyperliquidHyperliquid(HYPE)$68.772.53%
  • zcashZcash(ZEC)$927.49-1.42%
  • dogecoinDogecoin(DOGE)$0.058950-0.45%
  • moneroMonero(XMR)$484.06-3.06%
  • leo-tokenLEO Token(LEO)$9.30-0.01%
  • USDSUSDS(USDS)$1.00-0.01%
  • whitebitWhiteBIT Coin(WBT)$61.23-0.24%
  • chainlinkChainlink(LINK)$9.09-0.55%
  • cardanoCardano(ADA)$0.1537260.65%
  • Ethena USDeEthena USDe(USDE)$1.000.04%
  • stellarStellar(XLM)$0.134536-4.08%
  • daiDai(DAI)$1.000.02%
  • nearNEAR Protocol(NEAR)$3.310.62%
  • bitcoin-cashBitcoin Cash(BCH)$207.52-0.69%
  • litecoinLitecoin(LTC)$43.06-2.23%
  • CantonCanton(CC)$0.082379-0.90%
  • avalanche-2Avalanche(AVAX)$7.070.20%
  • RainRain(RAIN)$0.004407-3.48%
  • uniswapUniswap(UNI)$4.99-4.45%
  • tether-goldTether Gold(XAUT)$3,680.28-1.53%
  • suiSui(SUI)$0.72-0.59%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.030.40%
  • USD1USD1(USD1)$1.000.01%
  • Ripple USDRipple USD(RLUSD)$1.000.00%
  • Global DollarGlobal Dollar(USDG)$1.000.00%
  • hedera-hashgraphHedera(HBAR)$0.055437-2.45%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.03%
  • BittensorBittensor(TAO)$194.760.27%
  • shiba-inuShiba Inu(SHIB)$0.0000040.75%
  • quant-networkQuant(QNT)$151.34-1.04%
  • crypto-com-chainCronos(CRO)$0.041508-3.69%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • Spiko Amundi Overnight Swap Fund (EUR)Spiko Amundi Overnight Swap Fund (EUR)(EURSAFO)$1.120.07%
  • MemeCoreMemeCore(M)$0.85-5.71%
  • okbOKB(OKB)$87.730.79%
  • Falcon USDFalcon USD(USDF)$1.000.03%
  • pax-goldPAX Gold(PAXG)$3,680.27-1.53%
  • United StablesUnited Stables(U)$1.000.02%
  • pepePepe(PEPE)$0.0000041.40%
  • aaveAave(AAVE)$104.17-4.97%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Scientists genetically engineer bacteria to detect cancer cells

August 11, 2023
in AI & Technology
Reading Time: 2 mins read
A A
Scientists genetically engineer bacteria to detect cancer cells
ShareShareShareShareShare

An international team of scientists has developed a new technology that can help detect (or even treat) cancer in hard-to-reach places, such as the colon. The team has published a paper in Science for the technique dubbed CATCH, or cellular assay for targeted, CRISPR-discriminated horizontal gene transfer. For their lab experiments, the scientists used a species of bacterium called Acinetobacter baylyi. This bacterium has the ability to naturally take up free-floating DNA from its surroundings and then integrate it into its own genome, allowing it to produce new protein for growth.  

What the scientists did was engineer A. baylyi bacteria so that they’d contain long sequences of DNA mirroring the DNA found in human cancer cells. These sequences serve as some sort of one-half of a zipper that locks on to captured cancer DNA. For their tests, the scientists focus on the mutated KRAS gene that’s commonly found in colorectal tumors. If an A. baylyi bacterium finds a mutated DNA and integrates it into its genome, a linked antibiotic resistance gene also gets activated. That’s what the team used to confirm the presence of cancer cells: After all, only bacteria with active antibiotic resistance could grow on culture plates filled with antibiotics. 

YOU MAY ALSO LIKE

Anthropic IPO Highlights AI’s Private Market Wealth

Genesis AI Hits $3.5B Valuation in Robotics Bet

While the scientists were successfully able to detect tumor DNA in mice injected with colorectal cancer cells in the lab, the technology is still not ready to be used for actual diagnosis. The team said it’s still working on the next steps, including improving the technique’s efficiency and evaluating how it performs compared to other diagnostic tests. “The most exciting aspect of cellular healthcare, however, is not in the mere detection of disease. A laboratory can do that,” Dan Worthley, one of the study’s authors, wrote in The Conversation. In the future, the technology could also be used for targeted biological therapy that can deploy treatment to specific parts of the body based on the presence of certain DNA sequences. 

Credit: Source link

ShareTweetSendSharePin

Related Posts

Anthropic IPO Highlights AI’s Private Market Wealth
AI & Technology

Anthropic IPO Highlights AI’s Private Market Wealth

November 19, 2026
Genesis AI Hits .5B Valuation in Robotics Bet
AI & Technology

Genesis AI Hits $3.5B Valuation in Robotics Bet

November 19, 2026
How To Adjust And Turn Off Motion Blur In GTA 6 If It Makes You Feel Sick
AI & Technology

How To Adjust And Turn Off Motion Blur In GTA 6 If It Makes You Feel Sick

November 19, 2026
Jensen Huang Says He’s Willing to Come Back as CEO
AI & Technology

Jensen Huang Says He’s Willing to Come Back as CEO

November 19, 2026
Next Post
Trex CEO: Harsh Winter Elevating Deck Repair Demand

Trex CEO: Harsh Winter Elevating Deck Repair Demand

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
What’s going on with the midterm elections? Why do they matter?

What’s going on with the midterm elections? Why do they matter?

November 14, 2026
OpenAI sued by California over hacking incidents on Hugging Face, other companies

OpenAI sued by California over hacking incidents on Hugging Face, other companies

November 16, 2026
Two injured dogs rescued after Russian attack on Kyiv

Two injured dogs rescued after Russian attack on Kyiv

November 16, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!